T1	Participants 479 556	9 clinics in the Netherlands, Belgium, Ireland, the United Kingdom, and Italy
T2	Participants 575 667	94 patients treated with CBS coated tablets and 95 patients treated with CBS chewing tablets
T3	Participants 392 435	patients suffering from duodenal ulceration
